[{"address1": "201 Haskins Way", "address2": "Suite 230", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "(650) 407-2376", "website": "https://www.cero.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. Christopher B. Ehrlich M.B.A.", "age": 54, "title": "CEO & Chair", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1080000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew Albert Kucharchuk M.B.A.", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 252000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kristen  Pierce Ph.D.", "age": 53, "title": "Chief Development Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 360000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lawrence  Corey M.D.", "age": 77, "title": "Co-founder & Head of Scientific Advisory Board", "yearBorn": 1947, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.093, "open": 0.1, "dayLow": 0.085, "dayHigh": 0.1, "regularMarketPreviousClose": 0.093, "regularMarketOpen": 0.1, "regularMarketDayLow": 0.085, "regularMarketDayHigh": 0.1, "payoutRatio": 0.0, "beta": 0.32, "volume": 135911, "regularMarketVolume": 135911, "averageVolume": 2522525, "averageVolume10days": 2728330, "averageDailyVolume10Day": 2728330, "bid": 0.085, "ask": 0.09, "bidSize": 57043, "askSize": 21859, "marketCap": 181852, "fiftyTwoWeekLow": 0.062, "fiftyTwoWeekHigh": 572.0, "allTimeHigh": 25600.0, "allTimeLow": 0.062, "fiftyDayAverage": 3.32686, "twoHundredDayAverage": 12.76133, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6531655, "forwardPE": -0.024054054, "profitMargins": 0.0, "floatShares": 1179980, "sharesOutstanding": 1865147, "sharesShort": 192892, "sharesShortPriorMonth": 106183, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.1034, "heldPercentInsiders": 0.01727, "heldPercentInstitutions": 0.112349994, "shortRatio": 0.83, "shortPercentOfFloat": 0.105, "impliedSharesOutstanding": 2043281, "bookValue": -8.544, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -41912760, "trailingEps": -5.95, "lastSplitFactor": "1:20", "lastSplitDate": 1749772800, "enterpriseToEbitda": -0.392, "52WeekChange": -0.99979585, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 0.089, "targetHighPrice": 30.0, "targetLowPrice": 30.0, "targetMeanPrice": 30.0, "targetMedianPrice": 30.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 3302674, "totalCashPerShare": 2.74, "ebitda": -16679652, "totalDebt": 1152618, "quickRatio": 0.434, "currentRatio": 0.557, "returnOnAssets": -1.56888, "freeCashflow": -8613463, "operatingCashflow": -13367386, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CERO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "CERo Therapeutics Holdings, Inc.", "epsTrailingTwelveMonths": -5.95, "epsCurrentYear": -15.39, "priceEpsCurrentYear": -0.005782976, "fiftyDayAverageChange": -3.23786, "fiftyDayAverageChangePercent": -0.97324806, "twoHundredDayAverageChange": -12.67233, "twoHundredDayAverageChangePercent": -0.99302584, "priceToBook": -0.010416667, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Phoenix Biotech Acquisition Corp.", "nameChangeDate": "2025-11-14", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "corporateActions": [{"header": "Delisting", "message": "CERO was delisted effective Oct. 31, 2025", "meta": {"eventType": "DELISTING", "dateEpochMs": 1761886800000}}], "regularMarketTime": 1763153968, "exchange": "NCM", "messageBoardId": "finmb_1673740339", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.301076, "regularMarketPrice": 0.089, "marketState": "CLOSED", "shortName": "CERo Therapeutics Holdings, Inc", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1638282600000, "regularMarketChange": -0.0040000007, "regularMarketDayRange": "0.085 - 0.1", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2522525, "fiftyTwoWeekLowChange": 0.027000003, "fiftyTwoWeekLowChangePercent": 0.43548393, "fiftyTwoWeekRange": "0.062 - 572.0", "fiftyTwoWeekHighChange": -571.911, "fiftyTwoWeekHighChangePercent": -0.99984443, "fiftyTwoWeekChangePercent": -99.97958, "displayName": "CERo Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]